Phase I study of intraventricular administration of rituximab in combination with methotrexate in the treatment of recurrent CNS [central nervous system] and intraocular lymphoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Methotrexate; Rituximab
- Indications CNS cancer; Eye neoplasms; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 16 Feb 2015 Biomarkers information updated
- 28 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Jul 2007 Status changed from initiated.